Our reverse engineering approach to infer the first lung cancer-specific gene regulatory network from the lung cancer cell dataset without any a priori knowledge allowed us to distinguish two different states of cell activation: HGF-stimulated or not. The gene discussed is HGF; the disease is lung carcinoma.